Participants
B. Olaisen, Elly Herbschleb-Voogt, L.M.M. Wijnen, T.M. Dijksman, M.P. Cowmeadow, M.A. Ferguson‐Smith(Australian Research Council), P.L. Pearson, J.J. Garver, A. Estop, W.R.T. Los, John D. Minna(Center for Neuro-Oncology), P.A. Lalley, R. Saisson, Arvid Heiberg(Oslo University Hospital), Jeanne E. Anderson, Hiroko Kaita, Lynda J. Donald, M. Bobrow, E.R. Giblett(Public Health – Seattle & King County), H. M. Vriesendorp, Uta Francke(Stanford University), P. Meera Khan(Leiden University Medical Center), D.A. Aitken, W.S. Volkers, B.A. Doppert, D. S. Borgaonkar, Karin D. Berg, J.L. Hamerton, M. Lewis, E.B. Robson, P.J.L. Cook, J.E. Gray, Marry M. van den Heuvel, Richard M. Denney, A. Westerveld, F.H. Ruddle
Cited by 0
Related Papers
Age and acute myeloid leukemia
|Blood|2006|1.4k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963